follow-up period

Real-world outcomes after switching from standard therapy to efgartigimod in five patients with chronic inflammatory demyelinating polyradiculoneuropathy: a case series study in Japan

Study Overview This case series investigates the effects of transitioning from standard therapy to efgartigimod in patients diagnosed with chronic […]

Real-world outcomes after switching from standard therapy to efgartigimod in five patients with chronic inflammatory demyelinating polyradiculoneuropathy: a case series study in Japan Read Post »

Left atrial appendage closure for atrial fibrillation stroke prevention in hereditary hemorrhagic telangiectasia is effective and safe with simplified, time-limited antithrombotic therapy

Study Overview The study investigates the effectiveness and safety of left atrial appendage closure (LAAC) as a preventive measure against

Left atrial appendage closure for atrial fibrillation stroke prevention in hereditary hemorrhagic telangiectasia is effective and safe with simplified, time-limited antithrombotic therapy Read Post »

Predictors of Discontinuation of Angiotensin Converting Enzyme Inhibitors Use Among Medicare Beneficiaries Using Sodium-Glucose Cotransporter 2 Inhibitors

Study Overview The research investigates the discontinuation rates of Angiotensin Converting Enzyme (ACE) inhibitors among Medicare beneficiaries who are concurrently

Predictors of Discontinuation of Angiotensin Converting Enzyme Inhibitors Use Among Medicare Beneficiaries Using Sodium-Glucose Cotransporter 2 Inhibitors Read Post »

Scroll to Top